| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 963.00K | 1.04M | 1.52M | 1.32M | 2.94M | 3.62M |
| Gross Profit | 345.00K | 369.00K | 736.00K | 668.00K | 1.61M | 2.00M |
| EBITDA | -1.01M | -1.05M | -872.00K | -788.00K | -79.00K | 269.00K |
| Net Income | -1.22M | -1.26M | -1.17M | -748.00K | 174.00K | 343.00K |
Balance Sheet | ||||||
| Total Assets | 6.45M | 6.72M | 7.03M | 7.81M | 8.10M | 4.17M |
| Cash, Cash Equivalents and Short-Term Investments | 262.00K | 338.00K | 526.00K | 717.00K | 1.56M | 1.06M |
| Total Debt | 318.00K | 312.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 951.00K | 1.05M | 666.00K | 1.00M | 557.00K | 358.00K |
| Stockholders Equity | 5.50M | 5.68M | 6.37M | 6.80M | 7.55M | 3.81M |
Cash Flow | ||||||
| Free Cash Flow | -1.39M | -944.00K | -1.03M | -845.00K | -142.00K | 204.00K |
| Operating Cash Flow | -1.32M | -868.00K | -1.02M | -816.00K | -118.00K | 254.00K |
| Investing Cash Flow | -19.00K | -78.00K | -30.00K | -29.00K | -2.87M | -50.00K |
| Financing Cash Flow | 1.29M | 758.00K | 857.00K | 150.00K | 3.49M | 0.00 |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | £405.90M | 9.36 | 3.72% | 4.05% | -2.22% | ― | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | £896.49M | 16.71 | 9.32% | 2.11% | -6.03% | 13.11% | |
54 Neutral | £56.60M | -32.71 | -6.01% | ― | ― | ― | |
47 Neutral | £22.30M | -2.40 | ― | ― | 0.43% | 15.06% | |
41 Neutral | £915.21K | -0.96 | -21.81% | ― | -25.00% | 52.94% |